A multi-center randomized prospective study on the treatment of infant bronchiolitis with interferon α1b nebulization

BACKGROUND: The respiratory syncytial virus (RSV) is the main cause of bronchiolitis in infants and interferon (IFN) α is a commercial antiviral drug. The nebulization of IFN α1b could be a viable treatment method. In this study, the therapeutic effects and safety of IFN α1b delivery via nebulizatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lina, Shi, Mingfang, Deng, Quanmin, Liu, Wenjun, Li, Qin, Ye, Piao, Yu, Xiahui, Zhang, Benjin, Xu, Yuxia, Li, Xiaolan, Yang, Yao, Li, Min, Yan, Yi, Xu, Zhe, Yu, Jing, Xiang, Long, Tang, Xiaojun, Wan, Guangping, Cai, Qiang, Wang, Li, Hu, Bo, Xie, Liang, Li, Gen, Xie, Lunyan, Liu, Xiaoyun, Liu, Chunyan, Li, Li, Chen, Lijie, Jiang, Xiaobin, Huang, Yana, Wang, Si, Guo, Jiang, Shi, Yan, Wang, Xiaofang, Zhao, Zhiyong, Li, Yan, Liu, Yanru, Fu, Qiang, Zeng, Yan, Zou, Yan, Liu, Dingyuan, Wan, Deyun, Ai, Tao, Liu, Hanmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034796/
https://www.ncbi.nlm.nih.gov/pubmed/32084142
http://dx.doi.org/10.1371/journal.pone.0228391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034796/
https://www.ncbi.nlm.nih.gov/pubmed/32084142
http://dx.doi.org/10.1371/journal.pone.0228391

Ejemplares similares